Japanese Pharmacology & Therapeutics（JPT）
Vol. 30 No. 9 2002
Japanese clinical trials and frameworks for evaluation
S.Ono
Jpn Pharmacol Ther 2002 30（9）629
A double blind comparison of efficacy and safety of BIBR277 (Telmisartan), the long-acting angiotensinII AT1
receptor antagonist, and enalapril maleate in patients with mild-to-moderate essential hypertension
─Multicenter, randamised, double-blind study ─
K. Arakawa, et al.
Jpn Pharmacol Ther 2002 30（9）639
Efficacy and safety of an angiotensin II AT1 receptor antagonist, BIBR277 (Telmisartan), in patients with chronic heart failure
─Pilot study─
S. Sasayama, et al.
Jpn Pharmacol Ther 2002 30（9）661
Clinical evaluation of Pariet 10 mg tablets in patients with gastric ulcer diseases
K. Saigenji, et al.
Jpn Pharmacol Ther 2002 30（9）675
Clinical pharmacokinetic study of the ultrasound contrast agent YM454
M. Ohto, et al.
Jpn Pharmacol Ther 2002 30（9）695
Pharmacological properties of azelnidipine, a long-acting calcium channel blocker with high-affinity for vascular tissues (Part 1)─Calcium-channel blocking actions in receptor binding and isolated blood vessel studies─
T. Sada, et al.
Jpn Pharmacol Ther 2002 30（9）703
Pharmacological properties of azelnidipine, a long-acting calcium channel blocker with high-affinity
for vascular tissues (Part 2)
─Antihypertensive effects and pharmacokinetics in spontaneously hypertensive rats (SHR)─
T. Sada, et al.
Jpn Pharmacol Ther 2002 30（9）711
Antiatherosclerotic effects of azelnidipine, a long-acting and lipophilic Ca channel blocker, in cholesterol-fed rabbits
T. Sada, et al.
Jpn Pharmacol Ther 2002 30（9）721
Present and future of clinical pharmacology in Taiwan
HD. Chern
Jpn Pharmacol Ther 2002 30（9）759
Present and future of clinical pharmacology in Korea
SG. Shin
Jpn Pharmacol Ther 2002 30（9）761
Clinical pharmacology in Singapore
─Current status and future developments─
EJD. Lee
Jpn Pharmacol Ther 2002 30（9）763
The current status and perspective of clinicalpharmacology in Japan
K. Ohashi
Jpn Pharmacol Ther 2002 30（9）765
Paradigm shift of clinical development in Japan & Korea and China current situation
K. Nakamura
Jpn Pharmacol Ther 2002 30（9）767
Panel Discussion
Jpn Pharmacol Ther 2002 30（9）771